Deferred Tax Assets, Operating Loss Carryforwards of AYTU BIOPHARMA, INC from 31 Aug 2011 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
AYTU BIOPHARMA, INC quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Aug 2011 to 30 Jun 2025.
  • AYTU BIOPHARMA, INC Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Jun 2025 was $119,782,000, a 0.51% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

AYTU BIOPHARMA, INC Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $119,782,000 +$612,000 +0.51% 30 Jun 2025 10-K 23 Sep 2025 2025 FY
Q2 2024 $119,170,000 +$5,351,000 +4.7% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q2 2023 $113,819,000 -$624,000 -0.54% 30 Jun 2023 10-K 26 Sep 2024 2024 FY
Q2 2022 $114,443,000 +$7,731,000 +7.2% 30 Jun 2022 10-K 12 Oct 2023 2023 FY
Q2 2021 $106,712,000 +$69,521,000 +187% 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q2 2020 $37,191,000 +$19,106,000 +106% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q2 2019 $18,085,000 +$3,627,000 +25% 30 Jun 2019 10-K 06 Oct 2020 2020 FY
Q2 2018 $14,458,000 -$977,000 -6.3% 30 Jun 2018 10-K 26 Sep 2019 2020 FY
Q2 2017 $15,435,000 +$6,233,000 +68% 30 Jun 2017 10-K 06 Sep 2018 2018 FY
Q2 2016 $9,202,000 +$2,865,000 +45% 30 Jun 2016 10-K 31 Aug 2017 2017 FY
Q2 2015 $6,337,000 +$2,490,000 +65% 30 Jun 2015 10-K 01 Sep 2016 2016 FY
Q2 2014 $3,847,000 30 Jun 2014 10-K 28 Sep 2015 2015 FY
Q3 2012 $122,700 +$14,900 +14% 31 Aug 2012 10-K 29 Nov 2012 2012 FY
Q3 2011 $107,800 31 Aug 2011 10-K 29 Nov 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.